Has the Ship Sailed on Second-Generation ALK Tyrosine Kinase Inhibitors in the Post-Crizotinib Setting?

Subjects

Subjects :

Humans
Crizotinib
Drug Resistance, Neoplasm
Protein Kinase Inhibitors therapeutic use
Protein Kinase Inhibitors pharmacology
Receptor Protein-Tyrosine Kinases
Lung Neoplasms
Tyrosine Kinase Inhibitors

Details

Language :

English

ISSN :

1556-1380

Volume :

18

Issue :

12

Database :

MEDLINE

Journal :

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Publication Type :

Editorial & Opinion

Accession number :

37993214

Full Text :

https://doi.org/10.1016/j.jtho.2023.09.1438